Filed before 2025Filed 21 March 2023
Cellanome, Inc. has sold $40.7M so far
Cellanome, Inc., a biotech company based in Palo Alto, CA, has sold $40.7M so far in its equity round, according to a filing dated 21 March 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 21 March 2023
- First filed
- 5 August 2022
- Round
- Equity round (amended filing)
- Amount sold
- $40.7M
- Offering size
- $40.7M
- Investors so far
- 11
- Based in
- Palo Alto, CA
- Website
- cellanome.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 91% of the 1,396 tracked raises with an amount filed in 2023, and than 77% of the 142 in biotech.
Cellanome, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 22 Jun 2026 | New filing | $75.9M | Another raise |
| 29 Jan 2024 | New filing | $150M | Another raise |
| 21 Mar 2023 | Amended filing | $40.7M | This raise |
| 5 Aug 2022 | New filing | $30M | This raise |
More with Bakar Entrepreneurship on the board
- PinkDx, Inc.$17M
- Vineti, Inc.$33.5M
- Menlo Microsystems, Inc.$22.5M
- Evidation Health, Inc.$10M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.